Nabumetone-d 3

Overview

Nabumetone -d 3 is the deuterium labeled Nabumetone ( HY-B0559 ). Nabumetone is an orally active non-acidic anti-inflammatory agent, acts as a potent and selective COX-2 inhibitor, and is the proagent of the active metaboliteα-Demethylnaproxen ( HY-W086896 ). Nabumetone can inhibit cancer cells proliferation and relieve gastric ulcers.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > COX

Product Information

• Catalog No.: HY-B0559S
• CAS No.: 1216770-08-9
• Molecular Formula: C15H13D3O2
• Molecular Weight: 231.30
• Purity: 98.80%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source